{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:22:55Z","timestamp":1777897375893,"version":"3.51.4"},"reference-count":67,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F30 DA044700"],"award-info":[{"award-number":["F30 DA044700"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F30 DA052972"],"award-info":[{"award-number":["F30 DA052972"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA015815"],"award-info":[{"award-number":["UG1DA015815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Greenlick Family Scholarship, the OHSU MD\/PhD Program, National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR002371"],"award-info":[{"award-number":["TL1TR002371"]}],"id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Veterans Affairs Health Services Research & Development","award":["I01HX002518"],"award-info":[{"award-number":["I01HX002518"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>Background: As the drug-related overdose crisis and COVID-19 pandemic continue, communities need increased access to medications for opioid use disorder (MOUD) (i.e., buprenorphine and methadone). Disparities in the type of MOUD prescribed or administered by racial and ethnic categories are well described in the outpatient clinical environment. It is unknown, however, if these disparities persist when MOUD is provided in acute care hospitals. Methods: This study assessed differences in the delivery of buprenorphine versus methadone during acute medical or surgical hospitalizations for veterans with opioid use disorder (OUD) by racial categories (Black Non-Hispanic or Latino vs. White Non-Hispanic or Latino). Data were obtained retrospectively from the Veterans Health Administration (VHA) for federal fiscal year 2017. We built logistic regression models, adjusted for individual and hospital-related covariates, and calculated the predicted probabilities of MOUD delivery by racial categories. Results: The study cohort ( n\u2009=\u20091,313 unique patients; N\u2009=\u2009107 VHA hospitals) had a mean age of 57 (range 23 to 87\u2009years), was predominantly male (96%), and composed entirely of Black (29%) or White (71%) patients. White patients were 11% more likely than Black patients to receive buprenorphine than methadone during hospitalization ( p\u2009=\u20090.010; 95% CI: 2.7%, 20.0%). Among patients on MOUD prior to hospitalization, White patients were 21% more likely than Black patients to receive buprenorphine ( p\u2009=\u20090.000; 95% CI: 9.8%, 31.5%). Among patients newly initiated on MOUD during hospitalization, there were no differences by racial categories. Conclusion: We observed disparities in the delivery of buprenorphine versus methadone during hospitalization by racial categories. The observed differences in hospital-based MOUD delivery may be influenced by MOUD received prior to hospitalization within the racialized outpatient addiction treatment system. The VHA and health systems more broadly must address all aspects of racism that contribute to inequitable MOUD access throughout all clinical contexts.<\/jats:p>","DOI":"10.1080\/08897077.2022.2074601","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T10:56:05Z","timestamp":1654599365000},"page":"1251-1259","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Differences in the Delivery of Medications for Opioid use Disorder during Hospitalization by Racial Categories: A Retrospective Cohort Analysis;"],"prefix":"10.1177","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-8177","authenticated-orcid":false,"given":"Kelsey C.","family":"Priest","sequence":"first","affiliation":[{"name":"School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9913-6340","authenticated-orcid":false,"given":"Caroline A.","family":"King","sequence":"additional","affiliation":[{"name":"School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1863-2041","authenticated-orcid":false,"given":"Honora","family":"Englander","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine & Section of Addiction Medicine, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis I.","family":"Lovejoy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, Oregon, USA"},{"name":"School of Public Health, Oregon Health & Science University-Portland State University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-2894","authenticated-orcid":false,"given":"Dennis","family":"McCarty","sequence":"additional","affiliation":[{"name":"School of Public Health, Oregon Health & Science University-Portland State University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"bibr1-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"bibr2-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8969"},{"key":"bibr3-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108040"},{"key":"bibr4-08897077.2022.2074601","first-page":"CD002207","volume":"2","author":"Mattick RP","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr5-08897077.2022.2074601","unstructured":"Substance Abuse Mental Health Services Administration. Federal guidelines for opioid treatment programs. In. Vol Vol HHS Publication No.(SMA) PEP 15-FEDGUIDEOTP2015; 2015."},{"key":"bibr6-08897077.2022.2074601","unstructured":"National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder save Lives. Washington, DC: The National Academies Press; 2019."},{"key":"bibr7-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1111\/add.15190"},{"key":"bibr8-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1108\/S1057-6290(2012)0000014008"},{"key":"bibr9-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1177\/1073110518782949"},{"key":"bibr10-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1177\/0162243920912812"},{"key":"bibr11-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11013-016-9496-5"},{"key":"bibr12-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-013-9341-3"},{"key":"bibr13-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5734"},{"key":"bibr14-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3711"},{"key":"bibr15-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06266-3"},{"key":"bibr16-08897077.2022.2074601","volume-title":"Achieving Hospital-Wide Patient Flow","author":"Rutherford PA","year":"2017"},{"key":"bibr17-08897077.2022.2074601","unstructured":"Priest KC. Hospital-based services for opioid use disorder: a study of supply-side attributes.\n                      Dissertations and Theses.\n                      2019; p. 4829."},{"key":"bibr18-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.2736"},{"key":"bibr19-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3919-4"},{"key":"bibr20-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.2556"},{"key":"bibr21-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05251-9"},{"key":"bibr22-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05815-0"},{"key":"bibr23-08897077.2022.2074601","volume":"10","author":"Boyd RW","year":"2020","journal-title":"Health Affairs Blog"},{"key":"bibr24-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.20.2709"},{"key":"bibr25-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.90.8.1212"},{"key":"bibr26-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.2307\/4149999"},{"key":"bibr27-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.077628"},{"key":"bibr28-08897077.2022.2074601","unstructured":"Stata: Statsitics\/Data Analysis\n                      [computer program]. College Station: StatCorp LLC; 2017."},{"key":"bibr29-08897077.2022.2074601","unstructured":"R: A language and environment for statistical computing\n                      [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2018."},{"key":"bibr30-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686"},{"key":"bibr31-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v040.i01"},{"key":"bibr32-08897077.2022.2074601","volume-title":"An [R] Companion to Applied Regression, Third Edition","volume":"2","author":"Fox J","year":"2019"},{"key":"bibr33-08897077.2022.2074601","unstructured":"dplyr: A Grammar of Data Manipulation.\n                      [computer program]. Version R package version 0.8.32019; 2019."},{"key":"bibr34-08897077.2022.2074601","unstructured":"icd: Comorbidity Calculations and Tools for ICD-9 and ICD-10 Codes\n                      [computer program]. 2019."},{"key":"bibr35-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0587.2012.07348.x"},{"key":"bibr36-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1201200307"},{"key":"bibr37-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.soc.34.040507.134631"},{"issue":"13","key":"bibr38-08897077.2022.2074601","volume":"3","author":"Rogers W.","year":"1994","journal-title":"Stata technical bulletin"},{"key":"bibr39-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1640831"},{"key":"bibr40-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000719"},{"key":"bibr41-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05645-0"},{"key":"bibr42-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.12.035"},{"key":"bibr43-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12553"},{"key":"bibr44-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-019-0227-0"},{"key":"bibr45-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.06.005"},{"key":"bibr46-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108146"},{"key":"bibr47-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228755"},{"key":"bibr48-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.12.003"},{"key":"bibr49-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1803982"},{"key":"bibr50-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4801-3"},{"key":"bibr51-08897077.2022.2074601","unstructured":"HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder [press release]. 2021."},{"key":"bibr52-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2020.05.007"},{"key":"bibr53-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108218"},{"key":"bibr54-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000703"},{"key":"bibr55-08897077.2022.2074601","first-page":"1","volume":"2021","author":"Earp BD","year":"2021","journal-title":"Am J Bioethics."},{"key":"bibr56-08897077.2022.2074601","unstructured":"Culbert L. Fumano D. B.C. to offer Canada's first, permanent safe drug supply in response to overdose crisis.\n                      Vancouver Sun\n                      . 2021."},{"key":"bibr57-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108681"},{"key":"bibr58-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1353\/dem.0.0017"},{"key":"bibr59-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.2190\/HS.44.4.c"},{"issue":"2","key":"bibr60-08897077.2022.2074601","first-page":"13","volume":"11","author":"Groos M","year":"2018","journal-title":"J Health Disparit Res Pract"},{"issue":"6","key":"bibr61-08897077.2022.2074601","first-page":"371","volume":"26","author":"Cheng HG","year":"2014","journal-title":"Shanghai Arch Psychiatry."},{"key":"bibr62-08897077.2022.2074601","unstructured":"National Academies of Sciences E, Medicine. Communities in Action: Pathways to Health Equity. Washington, DC: National Academies Press; 2017."},{"key":"bibr63-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-014-3102-8"},{"key":"bibr64-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000644"},{"key":"bibr65-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.90.11.1738"},{"key":"bibr66-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000611"},{"key":"bibr67-08897077.2022.2074601","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107968"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2022.2074601","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2022.2074601","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2022.2074601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:56:52Z","timestamp":1777625812000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2022.2074601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1080\/08897077.2022.2074601"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2022.2074601","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}